O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.5%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.33B
AUM Growth
+$8.33B
(+4%)
Cap. Flow
-$6.28M
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
150
New
16
Increased
26
Reduced
35
Closed
6
Top Buys
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$326M |
| 2 |
Elevance Health
ELV
|
$127M |
| 3 |
AGN
Allergan plc
AGN
|
$98.8M |
| 4 |
Dentsply Sirona
XRAY
|
$94.9M |
| 5 |
Inspire Medical Systems
INSP
|
$87.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$204M |
| 2 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$154M |
| 3 |
AbbVie
ABBV
|
$145M |
| 4 |
Tenet Healthcare
THC
|
$128M |
| 5 |
Bristol-Myers Squibb
BMY
|
$71.7M |
Sector Composition
| 1 | Healthcare | 94.35% |
| 2 | Financials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $388M | 4.63% | 3,124,603 -143,672 | -4% | -$17.8M |
|
2
Biogen
BIIB
$19.4B
| $339M | 4.04% | 1,167,900 +127,500 | +12% | +$37M |
|
|
TCDA
3
DELISTED
Tricida, Inc. Common Stock
TCDA
| $326M | 3.88% | +10,889,280 | New | +$326M |
|
4
Boston Scientific
BSX
$156B
| $313M | 3.73% | 9,574,695 -803,100 | -8% | -$26.3M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $305M | 3.63% | 1,792,600 -62,000 | -3% | -$10.5M |
|
6
Ascendis Pharma
ASND
$11.8B
| $294M | 3.5% | 4,413,291 +1,045,976 | +31% | +$69.6M |
|
7
Merck
MRK
$210B
| $284M | 3.39% | 4,680,000 -608,200 | -12% | -$36.9M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $214M | 2.56% | 1,286,205 +592,600 | +85% | +$98.8M |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $204M | 2.44% | 2,570,650 -63,600 | -2% | -$5.05M |
|
10
Jazz Pharmaceuticals
JAZZ
$7.75B
| $179M | 2.14% | 1,040,100 | – | – |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $164M | 1.96% | 6,322,668 -529,400 | -8% | -$13.7M |
|
12
Puma Biotechnology
PBYI
$254M
| $162M | 1.93% | 2,732,881 +91,220 | +3% | +$5.4M |
|
|
CMTA
13
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $137M | 1.64% | 10,425,225 | – | – |
|
14
Viatris
VTRS
$12.3B
| $134M | 1.6% | 3,702,800 +1,868,500 | +102% | +$67.5M |
|
|
15
Bristol-Myers Squibb
BMY
$96B
| $132M | 1.57% | 2,380,300 -1,295,000 | -35% | -$71.7M |
|
|
16
Regeneron Pharmaceuticals
REGN
$61.5B
| $129M | 1.53% | 372,500 -590,400 | -61% | -$204M |
|
|
AERI
17
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $127M | 1.52% | 1,884,100 | – | – |
|
18
Edwards Lifesciences
EW
$47.8B
| $127M | 1.51% | 870,900 -153,700 | -15% | -$22.4M |
|
|
19
Elevance Health
ELV
$71.8B
| $127M | 1.51% | +531,800 | New | +$127M |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $125M | 1.49% | 1,265,966 | – | – |
|
21
Thermo Fisher Scientific
TMO
$186B
| $121M | 1.44% | 583,500 +194,100 | +50% | +$40.2M |
|
22
DaVita
DVA
$9.85B
| $117M | 1.4% | 1,689,400 +129,800 | +8% | +$9.01M |
|
|
IMMU
23
DELISTED
Immunomedics Inc
IMMU
| $117M | 1.4% | 4,944,573 -766,201 | -13% | -$18.1M |
|
24
Agilent Technologies
A
$35.7B
| $117M | 1.39% | 1,885,100 -951,800 | -34% | -$58.9M |
|
25
Amicus Therapeutics
FOLD
$2.34B
| $110M | 1.32% | 7,072,500 | – | – |
|